ThinkEquity Starts Emergent BioSolutions (EBS) at Buy
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.39 +1.82%
Rating Summary:
12 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 39
Rating Summary:
12 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 39
Join SI Premium – FREE
ThinkEquity initiates coverage on Emergent BioSolutions (NYSE: EBS) with a Buy. PT $26.00.
For more ratings news on Emergent BioSolutions click here and for the rating history of Emergent BioSolutions click here.
Shares of Emergent BioSolutions closed at $16.98 yesterday.
For more ratings news on Emergent BioSolutions click here and for the rating history of Emergent BioSolutions click here.
Shares of Emergent BioSolutions closed at $16.98 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein SocGen Group Starts Colgate-Palmolive Company (CL) at Market Perform
- Bernstein SocGen Group Starts Procter & Gamble (PG) at Market Perform
- RBC Capital Starts Guardant Health (GH) at Outperform, 'Underpenetrated Market'
Create E-mail Alert Related Categories
New CoverageRelated Entities
ThinkEquitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
